Only a few of the radioimmunoassays for vasopressin (AVP) published previously (Dunn, Brennan, Nelson & Robertson, 1973; M\l=o"\hring & M\l=o"\hring,1975) Solid AVP antiserum (0-5 ml at a dilution of 1 : 170) was added to single or duplicate plasma samples (1 ml or less) in 2 ml polystyrene tubes to give a final antiserum dilution of 1 : 510 and a final volume of 1-5 ml. Plasma samples of less than 1 ml were made up to 1 ml with 0-9% saline. The samples were extracted by mixing end-over-end for 18 h at 4°C. The tubes were then centrifuged and the plasma discarded. The solid antiserum containing the extracted AVP was washed twice with 2 ml water and centrifuged after each wash. The extracted AVP was eluted from the solid antiserum by mixing end-over-end for 30 min at room temperature with 1 ml 0-05 M-acetic acid, pH 3-1. The elution was repeated and the combined acetic acid extracts dried under a stream of air. The dried extracts were dissolved in 0-05 M-Tris-HCl, pH 7-5, and 50 µ samples were removed for assay. Each assay also included duplicate stan¬ dards of between 0-125 and 8-0 fmol synthetic AVP in 50 µ Tris-HCl, pH 7-5. To these standards or to unknown plasma extracts were added AVP antiserum at a dilution of 1 : 3500 (kindly supplied by Dr J. Möhring, Centre de Recherche, Merrell International, Strasbourg, France) and 1 fmol 125I-labelled AVP (50 µ ). Tubes were incubated for 2 days at + 5°C. The separation of bound and free labelled hormone was achieved using plasma-coated charcoal (0-5 ml). The smallest amount of AVP detectable was 0-2 fmol/tube.
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The recoveries of 100, 500 and 1000 fmol 125I-labelled AVP from human plasma were 65, 66 and 67% respectively and recoveries of 1,2-5,5 and 10 fmol unlabelled AVP in ten separate experiments were 58 ± 10 (s.d.), 64 ±11, 63 ± 10 and 62 + 8% respectively. The mean con¬ centration of AVP in the plasma of 15 normal subjects after overnight fasting and 30 min recumbency was 1-6 pmol/1 (range 0-9-2-3 pmol/1). After an oral water-load of 20 ml/kg in five subjects, the level of AVP in the plasma fell from 1 -9 ± 0-38 to 0-7 ± 0-3 pmol/1 (P < 001) ; after fluid deprivation for 24 h, the level rose from 2-1 to 2-9 pmol/1. The concentration of AVP in the plasma correlated with both plasma and urine osmolality (r The mean concentration of AVP in the plasma of five conscious, unrestrained rats who had been bled (1 ml) via a catheter in the carotid artery was 3-9 ± 1 -2 pmol/1. Sequential removal of 6-2 and 2-6 pmol/1 respectively; after the removal of 6 ml blood, the concentrations of AVP rose exponentially to 4008 and 701 pmol/1 respectively (Fig. 1) 
